Mutant IDH1 Enhances Temozolomide Sensitivity via Regulation of the ATM/CHK2 Pathway in Glioma
Lin Lin, Jinquan Cai, Zixiao Tan, Xiangqi Meng, Ruiyan Li, Yang Li, Chuanlu Jiang
Cancer Res Treat. 2021;53(2):367-377.   Published online 2020 Oct 13     DOI: https://doi.org/10.4143/crt.2020.506
Citations to this article as recorded by Crossref logo
Impact of NQO1 dysregulation in CNS disorders
Li Yuhan, Maryam Khaleghi Ghadiri, Ali Gorji
Journal of Translational Medicine.2024;[Epub]     CrossRef
Expression of molecular markers and synergistic anticancer effects of chemotherapy with antimicrobial peptides on glioblastoma cells
Alexandr N. Chernov, Alexandr V. Kim, Sofia S. Skliar, Evgeniy V. Fedorov, Anna N. Tsapieva, Tatiana A. Filatenkova, Aleksei L. Chutko, Marina V. Matsko, Elvira. S. Galimova, Olga V. Shamova
Cancer Chemotherapy and Pharmacology.2024;[Epub]     CrossRef
Oncometabolites as Regulators of DNA Damage Response and Repair
Susan E. Gueble, Ranjit S. Bindra
Seminars in Radiation Oncology.2022; 32(1): 82.     CrossRef
Perspective on the Use of DNA Repair Inhibitors as a Tool for Imaging and Radionuclide Therapy of Glioblastoma
Liesbeth Everix, Shankari Nair, Cathryn H. S. Driver, Ingeborg Goethals, Mike M. Sathekge, Thomas Ebenhan, Charlot Vandevoorde, Julie Bolcaen
Cancers.2022; 14(7): 1821.     CrossRef
Chk1/2 inhibitor AZD7762 enhances the susceptibility of IDH-mutant brain cancer cells to temozolomide
Erkin Ozgiray, Fatma Sogutlu, Cigir Biray Avci
Medical Oncology.2022;[Epub]     CrossRef
From Laboratory Studies to Clinical Trials: Temozolomide Use in IDH-Mutant Gliomas
Xueyuan Sun, Sevin Turcan
Cells.2021; 10(5): 1225.     CrossRef
From Metabolism to Genetics and Vice Versa: The Rising Role of Oncometabolites in Cancer Development and Therapy
Emanuela Di Gregorio, Gianmaria Miolo, Asia Saorin, Agostino Steffan, Giuseppe Corona
International Journal of Molecular Sciences.2021; 22(11): 5574.     CrossRef
The function and mechanism of the JARID2/CCND1 axis in modulating glioma cell growth and sensitivity to temozolomide (TMZ)
Weilu Kuang, Wuzhong Jiang, Yinyun Chen, Yifu Tian, Zhengzheng Liu
Cancer Biology & Therapy.2021; 22(5-6): 392.     CrossRef
Valproic Acid Enhanced Temozolomide-Induced Anticancer Activity in Human Glioma Through the p53–PUMA Apoptosis Pathway
Hong-Chieh Tsai, Kuo-Chen Wei, Pin-Yuan Chen, Chiung-Yin Huang, Ko-Ting Chen, Ya-Jui Lin, Hsiao-Wei Cheng, Yi-Rou Chen, Hsiang-Tsui Wang
Frontiers in Oncology.2021;[Epub]     CrossRef